#Japan #Daiichi Sankyo #Tokyo #LunaLuna #Norlevo

The Launch of Norlevo: A New Chapter in Women's Health

On January 14, 2026, Daiichi Sankyo Healthcare will launch the brand site for Norlevo, the first over-the-counter (OTC) emergency contraceptive in Japan. This initiative is aimed at providing detailed product information and facilitating easy access to purchase procedures for women in need of emergency contraception. The actual sale of Norlevo is set to commence on February 2, enabling women to find pharmacies and stores that offer the drug using a new store search system.

Comprehensive Support Platform

The company aims to create an environment that allows women to make swift decisions in urgent situations. The brand site will include resources such as a self-check page, which helps potential users confirm if they are eligible to take the medication, alongside educational content about contraception and access to consultation services.

The forthcoming launch will also feature a collaboration with the Lunaluna app, which is a women's health service. This partnership intends to support women from the moment of taking Norlevo until three weeks later, when pregnancy testing is recommended. The app will provide a medication record, notifications for health check-ups, and a wealth of information on contraception, all under the guidance of healthcare professionals.

Accessibility and User Privacy

The store search system will be available from February 2, enabling users to locate nearby pharmacies that stock Norlevo. Users can search by current location, station name, or address, and find out store details including contact numbers, operating hours, and privacy measures. As this system evolves, it's encouraged to call ahead for inventory confirmation.

Background and Importance

Surveys conducted by Daiichi Sankyo show that approximately 20% of Japanese women aged 18-49 have faced the risk of unplanned pregnancy. Such statistics highlight the necessity for reliable and rapid access to emergency contraception and associated information. With Norlevo, the company seeks to not only facilitate access to emergency contraception but also foster understanding of contraceptive methods among both men and women.

Product Details

Norlevo is an OTC medication formulated with the same ingredients as the prescription version, and will be available at pharmacies that meet specific regulations. It is crucial that women take the medication within 72 hours post-intercourse to prevent pregnancy effectively. Notably, only women can purchase Norlevo, and verification by trained pharmacists is mandatory at the time of purchase.

Final Thoughts

With the introduction of Norlevo, Daiichi Sankyo Healthcare is committed to providing a reliable and supportive framework for women's reproductive health. By facilitating access to emergency contraception and resources for informed decision-making, the company aims to empower women to take charge of their health and well-being.

For more information, visit the Norlevo brand site at Norlevo Site. For Lunaluna, more details can be found at Lunaluna Site.